Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Johanna Melo-Cardenas, Lavanya Bezavada, Jeremy Chase Crawford, Sandeep Gurbuxani, Anitria Cotton, Guolian Kang, Jeffrey Gossett, Christian Marinaccio, Rona Weinberg, Ronald Hoffman, Anna Rita Migliaccio, Yan Zheng, Marta Derecka, Ciro R. Rinaldi, John D. Crispino

Blood (2022) 140 (26): 2805–2817.

https://doi.org/10.1182/blood.2022017326

Published: 2022

Includes: Supplemental data

Journal Articles

Combination of Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis CD34+ Cells in Vitro. Proof of Concept for Combination Therapy

Kristian Boasman, Matthew J Simmonds, Ciro R Rinaldi

Blood (2022) 140 (Supplement 1): 12165–12166.

https://doi.org/10.1182/blood-2022-163769

Published: 2022

Journal Articles

Expression of CD47 and Calr in Myeloproliferative Neoplasms: Potential New Therapeutical Targets

Kristian Boasman, Matthew J Simmonds, Ciro R Rinaldi

Blood (2021) 138 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2021-144482

Published: 2021

Journal Articles

A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)

Adam J. Mead, MD PhD, Tim Somervaille, Professor, MD, Nauman M Butt, MD, Waseem Nagi, MD FRCPath, Alastair J Whiteway, MBBS, Suriya Kirkpatrick, MD, Ciro R Rinaldi, MD PhD, Catherine Roughley, MD, Sam Ackroyd, MD, Joanne Ewing, PhDBMBS BSc FRPATH, Pratap Neelakantan, MD FRCPath, Mamta Garg, MD FRCP, FRCPath, Claire N Harrison, Professor, David Tucker, MD, Rozinder Bains, Gavin Chiu, MBBS, MRCGP, MFPM, DPM, BSc, Joe Hickey, PhD

Blood (2019) 134 (Supplement_1): 1671.

https://doi.org/10.1182/blood-2019-124686

Published: 2019

Journal Articles

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

Kristian Boasman, BSc, MSc, Matthew J Simmonds, PhD, Ciro R Rinaldi, MD PhD

Blood (2019) 134 (Supplement_1): 5031.

https://doi.org/10.1182/blood-2019-128422

Published: 2019

Journal Articles

CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

Kristian Boasman, BSc, MSc, Matthew J Simmonds, PhD, Ciro R Rinaldi, MD PhD

Blood (2018) 132 (Supplement 1): 5492.

https://doi.org/10.1182/blood-2018-99-118266

Published: 2018

Journal Articles

Preferential nuclear accumulation of JAK2V617F in CD34 + but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia

Ciro R. Rinaldi, Paola Rinaldi, Adele Alagia, Marica Gemei, Nicola Esposito, Fabio Formiggini, Vincenzo Martinelli, Vitalyi Senyuk, Giuseppina Nucifora, Fabrizio Pane

Blood (2010) 116 (26): 6023–6026.

https://doi.org/10.1182/blood-2010-08-302265

Published: 2010

Journal Articles

Preferential Nuclear Accumulation of JAK2V617F In CD34+ but Not Granulocytic, Megakaryocytic or Erythroid Cells of Patients with Philadelphia-Negative Myeloproliferative Neoplasia

Ciro R Rinaldi, MD, Paola Rinaldi, Adele Alagia, Marica Gemei, Vitalyi Senyuk, PhD, Nicola Esposito, Fabio Formiggini, Vincenzo Martinelli, Anthony R. Green, PhD, FRCP, FRCPath, Giuseppina Nucifora, Fabrizio Pane, MD

Blood (2010) 116 (21): 4089.

https://doi.org/10.1182/blood.V116.21.4089.4089

Published: 2010

Journal Articles

JAK2V617F Mutation Persists IN Blasts and Mature CELLS of Transformed- JAK2V617F-POSITIVE-MYELOPROLIFERATIVE Neoplasia: A European LEUKEMIA NET (ENL) STUDY

Ciro R Rinaldi, MD, Paola Rinaldi, Adele Alagia, Marica Gemei, Luigi Del Vecchio, MD, Bruno Martino, Giorgina Specchia, Anna Candoni, Luigi Gugliotta, MD, Alessandro M. Vannucchi, MD, Tiziano Barbui, MD, Fabrizio Pane, MD

Blood (2010) 116 (21): 4090.

https://doi.org/10.1182/blood.V116.21.4090.4090

Published: 2010

Journal Articles

GATA1 Is Over-Expressed in Essential Thrombocytemia

Ciro R. Rinaldi, MD, Donglan Li, MD, Rosanna Ciancia, MD, Marco Picardi, MD, Paola Rinaldi, Vincenzo Martinelli, MD, Giuseppina Nucifora, PhD, Fabrizio Pane, MD, Bruno Rotoli, MD

Blood (2007) 110 (11): 1534.

https://doi.org/10.1182/blood.V110.11.1534.1534

Published: 2007

Journal Articles

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Andrea Camera, MD, Giuseppe Cerciello, MD, Fabiana Perna, MD, Ciro R. Rinaldi, MD, Elefanti Michele, Silvia Ferrari, Bruno Rotoli, MD

Blood (2006) 108 (11): 4540.

https://doi.org/10.1182/blood.V108.11.4540.4540

Published: 2006

Journal Articles

AML1/MDS1/EVI1 Induces Essential Thrombocythemia in Mice Independently of Jak2 Mutations.

Vitalyi Senyuk, PhD, Donglan Li, MD, PhD, Raffaella Fazzina, Francesca Cattaneo, PhD, Ciro R. Rinaldi, MD, Jerome Dickstein, MD, PhD, Giuseppina Nucifora, PhD

Blood (2006) 108 (11): 3622.

https://doi.org/10.1182/blood.V108.11.3622.3622

Published: 2006

Journal Articles

An EVI1 Point Mutant Unable To Bind GATA1 Rescues EVI1−Induced Defects in Erythroid Differentiation.

Leopoldo Laricchia-Robbio, PhD, Ciro R. Rinaldi, M.D., Raffaella Fazzina, Giuseppina Nucifora, Ph.D.

Blood (2006) 108 (11): 775.

https://doi.org/10.1182/blood.V108.11.775.775

Published: 2006

Journal Articles

Attenuated Essential Thrombocytemia Induced in Mice by the Expression of AML1/MDS1/EVI1 (AME) or an AME Mutant: Comparison between Two New Models of Myeloproliferative Disorders.

Ciro R. Rinaldi, MD, Vitaly Senyuk, PhD, Leopoldo Laricchia-Robbio, PhD, Jerome Dickstein, PhD, Giuseppina Nucifora, PhD

Blood (2006) 108 (11): 4898.

https://doi.org/10.1182/blood.V108.11.4898.4898

Published: 2006

NARROW

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Combination of Ruxolitinib and Magrolimab Significantly Increases Calreticulin Expression in Myelofibrosis CD34+ Cells in Vitro. Proof of Concept for Combination Therapy

Expression of CD47 and Calr in Myeloproliferative Neoplasms: Potential New Therapeutical Targets

A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

Preferential nuclear accumulation of JAK2V617F in CD34 + but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia

Preferential Nuclear Accumulation of JAK2V617F In CD34+ but Not Granulocytic, Megakaryocytic or Erythroid Cells of Patients with Philadelphia-Negative Myeloproliferative Neoplasia

JAK2V617F Mutation Persists IN Blasts and Mature CELLS of Transformed- JAK2V617F-POSITIVE-MYELOPROLIFERATIVE Neoplasia: A European LEUKEMIA NET (ENL) STUDY

GATA1 Is Over-Expressed in Essential Thrombocytemia

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

AML1/MDS1/EVI1 Induces Essential Thrombocythemia in Mice Independently of Jak2 Mutations.

An EVI1 Point Mutant Unable To Bind GATA1 Rescues EVI1−Induced Defects in Erythroid Differentiation.

Attenuated Essential Thrombocytemia Induced in Mice by the Expression of AML1/MDS1/EVI1 (AME) or an AME Mutant: Comparison between Two New Models of Myeloproliferative Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only